Literature DB >> 12221033

Screening guidelines for colorectal cancer and polyps in patients with acromegaly.

P J Jenkins1, P D Fairclough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12221033      PMCID： PMC1867734          DOI： 10.1136/gut.51.suppl_5.v13

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  27 in total

1.  Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; V Frajese; A M Jones; C Camacho-Hubner; D G Lowe; P D Fairclough; S L Chew; A B Grossman; J P Monson; G M Besser
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Acromegaly and gastrointestinal adenocarcinomas.

Authors:  F H Ziel; A L Peters
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

3.  Acromegaly and colon cancer.

Authors:  M M Ritter; W O Richter; P Schwandt
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

4.  Acromegaly and cancer.

Authors:  I Klein
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

5.  IGF-I and IGF-II in relation to colorectal cancer.

Authors:  O Manousos; J Souglakos; C Bosetti; A Tzonou; V Chatzidakis; D Trichopoulos; H O Adami; C Mantzoros
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

6.  Epidemiology of acromegaly in the Newcastle region.

Authors:  L Alexander; D Appleton; R Hall; W M Ross; R Wilkinson
Journal:  Clin Endocrinol (Oxf)       Date:  1980-01       Impact factor: 3.478

7.  Colonic polyps in patients with acromegaly.

Authors:  I Klein; G Parveen; J S Gavaler; D H Vanthiel
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

8.  Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer.

Authors:  J E Brunner; C C Johnson; S Zafar; E L Peterson; J F Brunner; R C Mellinger
Journal:  Clin Endocrinol (Oxf)       Date:  1990-01       Impact factor: 3.478

9.  Acromegaly and colon cancer.

Authors:  E A Ituarte; J Petrini; J M Hershman
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

10.  Gastrointestinal tumors in acromegalic patients.

Authors:  A Pines; P Rozen; E Ron; T Gilat
Journal:  Am J Gastroenterol       Date:  1985-04       Impact factor: 10.864
View more
  8 in total

1.  Colorectal screening guidelines in acromegaly.

Authors:  I Perry; P M Stewart; K Kane
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

2.  MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients.

Authors:  Maria Luisa Torre; Giuseppina T Russo; Marta Ragonese; Annalisa Giandalia; Ernesto De Menis; Giorgio Arnaldi; Angela Alibrandi; Carmelo Buda; Giovanni Romanello; Elisabetta L Romeo; Domenico Cucinotta; Francesco Trimarchi; Salvatore Cannavo
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

3.  Guidelines versus real life practice: the case of colonoscopy in acromegaly.

Authors:  M Parolin; F Dassie; L Russo; S Mazzocut; M Ferrata; E De Carlo; R Mioni; F Fallo; R Vettor; C Martini; P Maffei
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 4.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

5.  Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis.

Authors:  Gil Y Melmed; Shane M Devlin; George Vlotides; Deepti Dhall; Soraya Ross; Run Yu; Shlomo Melmed
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02-06       Impact factor: 11.382

6.  Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK.

Authors:  Rémi Marty; Stéphane Roze; Hannah Kurth
Journal:  Med Devices (Auckl)       Date:  2012-05-01

7.  A consensus on the diagnosis and treatment of acromegaly complications.

Authors:  S Melmed; F F Casanueva; A Klibanski; M D Bronstein; P Chanson; S W Lamberts; C J Strasburger; J A H Wass; A Giustina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

8.  Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.

Authors:  Whitney W Woodmansee; Murray B Gordon; Mark E Molitch; Adriana G Ioachimescu; Don W Carver; Beloo Mirakhur; David Cox; Roberto Salvatori
Journal:  Endocrine       Date:  2018-05-16       Impact factor: 3.633
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.